Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Variation in coagulation inhibitors during prolonged sitting: possible pathogenetic mechanisms for travel-associated thrombosis.

Stricker H, Colucci G, Alberio L, Mombelli G.

J Thromb Haemost. 2006 Apr;4(4):900-2. No abstract available.

2.
3.

Blood coagulation: hemostasis and thrombin regulation.

Tanaka KA, Key NS, Levy JH.

Anesth Analg. 2009 May;108(5):1433-46. doi: 10.1213/ane.0b013e31819bcc9c. Review.

PMID:
19372317
4.

Mechanisms of the factor V Leiden paradox.

van Stralen KJ, Doggen CJ, Bezemer ID, Pomp ER, Lisman T, Rosendaal FR.

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1872-7. doi: 10.1161/ATVBAHA.108.169524. Epub 2008 Jul 10.

5.

[Oral contraceptives and the risk of venous thromboembolism].

Uchikova E, Malinova M, Milchev N.

Akush Ginekol (Sofiia). 2002;41(2):46-8. Review. Bulgarian. No abstract available.

PMID:
12066553
6.

Thrombin generation in patients after acute deep-vein thrombosis.

ten Cate-Hoek AJ, Dielis AW, Spronk HM, van Oerle R, Hamulyák K, Prins MH, ten Cate H.

Thromb Haemost. 2008 Aug;100(2):240-5.

PMID:
18690343
7.

An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM.

Gastroenterology. 2009 Dec;137(6):2105-11. doi: 10.1053/j.gastro.2009.08.045. Epub 2009 Aug 23.

PMID:
19706293
8.

[Cerebral venous thrombosis and factor V Leiden].

Medrano V, Mallada-Frechín J, Fernández-Izquierdo S, Piqueras-Rodríguez L.

Rev Neurol. 2006 Jul 1-15;43(1):49-50. Spanish. No abstract available.

9.

The role of sulfatide in thrombogenesis and haemostasis.

Kyogashima M.

Arch Biochem Biophys. 2004 Jun 15;426(2):157-62. Review.

PMID:
15158666
10.

Cerebral venous thrombosis due to homozygous factor V Leiden mutation.

Aaron S, Alexander M, Thomas M, George B, Mammen J.

Neurol India. 2009 Jan-Feb;57(1):91. No abstract available.

11.

Sepsis and coagulation.

Aird WC.

Crit Care Clin. 2005 Jul;21(3):417-31. Review.

PMID:
15992665
13.

Coagulation and haemodialysis access thrombosis.

Smits JH, van der Linden J, Blankestijn PJ, Rabelink TJ.

Nephrol Dial Transplant. 2000 Nov;15(11):1755-60. Review. No abstract available.

PMID:
11071961
14.

Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma.

Auwerda JJ, Sonneveld P, de Maat MP, Leebeek FW.

Haematologica. 2007 Feb;92(2):279-80.

15.

Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.

Altinisik J, Ates O, Ulutin T, Cengiz M, Buyru N.

Clin Appl Thromb Hemost. 2008 Oct;14(4):415-20. Epub 2007 Dec 26.

PMID:
18160601
16.
17.

Clinical impact of hemostatic regulations.

Nossel HL.

Prog Clin Biol Res. 1981;72:163-77. No abstract available.

PMID:
6801685
18.

Basic mechanisms and pathogenesis of venous thrombosis.

Esmon CT.

Blood Rev. 2009 Sep;23(5):225-9. doi: 10.1016/j.blre.2009.07.002. Review.

19.

Haplotypes encoding the factor VIII 1241 Glu variation, factor VIII levels and the risk of venous thrombosis.

Nossent AY, Eikenboom JC, Vos HL, Bakker E, Tanis BC, Doggen CJ, Bertina RM, Rosendaal FR.

Thromb Haemost. 2006 Jun;95(6):942-8.

PMID:
16732372
20.

The effect of plasma substitutes on coagulation.

Eichler J, Stephan G.

Bibl Haematol. 1969;33:452-6. No abstract available.

PMID:
5377194

Supplemental Content

Support Center